Aviceda Therapeutics logo

Aviceda Therapeutics

Cambridge, MA

Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly.

avicedarx.com

Company Details

Founded

2018

Employees

Between 20 - 50 employees

Raised

$276,810,976

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

Mohamed GeneadMohamed Genead

Founders

Mohamed Genead
Mohamed Genead
Michael Tolentino
Michael Tolentino
Derek Kunimoto
Derek Kunimoto
Christopher Scott
Christopher Scott

Company Collections

These are collections Aviceda Therapeutics is a part of. Click on the collection name to view similar companies.

Aviceda Therapeutics' Industries